Hospital Mater Dei S.A. (BOVESPA:MATD3) agreed to acquire 95.5% stake in Hospital Premium for approximately BRL 250 million on January 11, 2022. Under the terms, 40% of the consideration will be paid upon conclusion of the operation, and the rest in four annual instalments of 10% and a final payment of 20% after five years, corrected for inflation. The transaction is approved by the board of Hospital Mater Dei. Inspire Capital Partners Assessoria Financeira Ltda. acted as the financial advisor to Hospital Mater Dei S.A.

Hospital Mater Dei S.A. (BOVESPA:MATD3) completed the acquisition of 95.5% stake in Hospital Premium in fourth quarter of 2022.